Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Physician Attitudes Towards Pharmacist-Prescribed HIV Post-Exposure Prophylaxis (PEP)

A Survey of a State Medical Association

Bibliographic Data

ID21427167
AuthorsKaylee Scarnati (0000-0002-7946-7935, University of Toledo, corresponding author), Katherine L Esser (0009-0008-8907-0094, University of Toledo), Julianna M Sim (0009-0009-6945-5074, University of Toledo), Varun Vaidya (0000-0002-7943-3479, University of Toledo), Eric G Sahloff (0000-0003-2132-615X, University of Toledo), Joan Duggan (0000-0002-3049-2355, University of Toledo Medical Center)
Year2025
Volume50
Issue2
Pages335-343
Publication date2025-04-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Community Health (JOURNAL)
Journal identifiersISSN: 0094-5145 • E-ISSN: 1573-3610
PublisherSpringer Science and Business Media LLC (PUBLISHER)
DOI10.1007/s10900-024-01421-x
PMID39633236
OpenAlexW4405022091
LanguageEN
References cited11

Timely initiation of antiretroviral therapy (ART) for non-occupational post-exposure prophylaxis (nPEP) is crucial in preventing HIV infection and advancing efforts to end the HIV epidemic (EHE). nPEP must be administered within 72 h of high-risk exposure, ideally within 24 h. Pharmacies may play a role in increasing access to nPEP and facilitating referrals for additional care, such as PrEP. Recent legislation permits pharmacist-prescribed nPEP (PDP), though provider attitudes toward this change have not been studied. A survey querying physicians and medical trainees (students and residents) was conducted in 2024 during an annual state medical association conference. The survey included 24 questions on nPEP knowledge and attitudes towards pharmacist-prescribed nPEP (PDP). The survey was administered in person using electronic tablets, with voluntary participation incentivized by a monetary reward. Statistical analysis was conducted using SAS (9.4 version) software, with differences in responses between physicians and trainees evaluated. P values

Family medicine · Human immunodeficiency virus (HIV) · Legislation · Opposition (politics) · Pharmacist · Post-exposure prophylaxis · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Pharmacy · Pneumocystis jirovecii pneumonia detection and treatment

  • Ending the HIV Epidemic

    Anthony S Fauci, R Redfield et al.•JAMA•2019

  • Epidemiology of HIV in the USA

    Open Access•Patrick S Sullivan, Anna Satcher Johnson et al.•The Lancet•2021

  • The Role of Community Pharmacies in Providing Access to HIV Post-exposure Prophylaxis (PEP)

    Open Access•Kaylee Scarnati, Katherine L Esser et al.•Journal of Community Health•2024

  • HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers

    Open Access•Steven A John, K G Quinn et al.•AIDS and Behavior•2020

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae